This site is intended for healthcare professionals
News

Pfizer and BioNTech choose lead mRNA vaccine candidate against COVID-19 and commence pivotal phase II/III global study.

Read time: 2 mins
Last updated:29th Jul 2020
Published:29th Jul 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com